Literature DB >> 14987247

Development of a health-related quality of life measure for boys with haemophilia: the Canadian Haemophilia Outcomes--Kids Life Assessment Tool (CHO-KLAT).

N L Young1, C S Bradley, V Blanchette, C D Wakefield, D Barnard, J K M Wu, P J McCusker.   

Abstract

Several measures of quality of life (QoL) are available for children with haemophilia. However, most are not disease-specific and few focus on children's perspectives. The purpose of this study was to develop a psychometrically sound measure of QoL that included the perspectives of boys with haemophilia. A list of potential items was developed from the literature, other measures, and input from five discussion sessions with adults with haemophilia, children with haemophilia and their parents and haemophilia nurses. The list was augmented with items generated by three focus groups with children and three focus groups with parents. These groups also prioritized items and recommended a domain structure. Supplemental information was gathered by surveying haematologists. Data from all sources were analysed to reduce the number of items using a two-step approach, based on rules that weighted the children's priorities most heavily. The remaining items were compiled into a questionnaire that was pilot tested with 10 children and their parents. The total item pool contained 228 potential items. Of these, 33 were removed based on three focus groups and survey responses, 72 were removed after the completion of all focus groups and 46 were removed due to redundancy. This resulted in a 77-item version of the CHO-KLAT. Pilot testing identified the need to subdivide two items, resulting in a 79-item CHO-KLAT. The CHO-KLAT is a promising disease-specific measure of QoL that reflects children's unique perspectives. This child-centric focus distinguishes the CHO-KLAT from alternative measures of QoL. Further research will assess the measurement properties of the CHO-KLAT.

Entities:  

Mesh:

Year:  2004        PMID: 14987247     DOI: 10.1111/j.1355-0691.2004.00877.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  13 in total

Review 1.  Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis.

Authors:  Scott D Grosse; Shraddha S Chaugule; Joel W Hay
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015-01-14       Impact factor: 2.217

2.  Issues in the measurement of quality of life in hemophilia.

Authors:  Brian M Feldman
Journal:  Rev Bras Hematol Hemoter       Date:  2013

Review 3.  Haemophilia.

Authors:  Erik Berntorp; Kathelijn Fischer; Daniel P Hart; Maria Elisa Mancuso; David Stephensen; Amy D Shapiro; Victor Blanchette
Journal:  Nat Rev Dis Primers       Date:  2021-06-24       Impact factor: 52.329

4.  Measuring the impact of hemophilia on families: Development of the Hemophilia Family Impact Tool (H-FIT).

Authors:  Saunya Dover; Nancy L Young; Victor S Blanchette; Robert J Klaassen; Anthony K Chan; Cindy Wakefield; Vanessa Bouskill; Manuel Carcao; Mark Belletrutti; Aisha A K Bruce; Victoria E Price
Journal:  Res Pract Thromb Haemost       Date:  2021-05-07

5.  Cross-cultural adaptation of the CHO-KLAT for boys with hemophilia in rural and urban China.

Authors:  Runhui Wu; Jishui Zhang; Koon Hung Luke; Xinyi Wu; Tricia Burke; Ling Tang; Man-Chiu Poon; Xiaojing Li; Min Zhou; Jing Sun; Marrisa Hang; Victor Blanchette; Nancy L Young
Journal:  Health Qual Life Outcomes       Date:  2012-09-15       Impact factor: 3.186

6.  Content comparison of haemophilia specific patient-rated outcome measures with the international classification of functioning, disability and health (ICF, ICF-CY).

Authors:  Silvia Riva; Monika Bullinger; Edda Amann; Sylvia von Mackensen
Journal:  Health Qual Life Outcomes       Date:  2010-11-25       Impact factor: 3.186

7.  Generic and disease-specific quality of life among youth and young men with Hemophilia in Canada.

Authors:  J St-Louis; D J Urajnik; F Ménard; S Cloutier; R J Klaassen; B Ritchie; G E Rivard; M Warner; V Blanchette; N L Young
Journal:  BMC Hematol       Date:  2016-05-05

8.  The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia.

Authors:  M W Skinner; C Chai-Adisaksopha; R Curtis; N Frick; M Nichol; D Noone; B O'Mahony; D Page; J S Stonebraker; A Iorio
Journal:  Pilot Feasibility Stud       Date:  2018-02-27

9.  Impact of prophylaxis on health-related quality of life of boys with hemophilia: An analysis of pooled data from 9 countries.

Authors:  Koyo Usuba; Victoria E Price; Victor Blanchette; Audrey Abad; Carmen Altisent; Loretta Buchner-Daley; Jorge D A Carneiro; Brian M Feldman; Kathelijn Fischer; John Grainger; Susanne Holzhauer; Koon-Hung Luke; Sandrine Meunier; Margareth Ozelo; Ling Tang; Sandra V Antunes; Paula Villaça; Cindy Wakefield; Gilian Wharfe; Runhui Wu; Nancy L Young
Journal:  Res Pract Thromb Haemost       Date:  2019-04-23

10.  Psychometric properties of the Greek Haem-A-QoL for measuring quality of life in Greek haemophilia patients.

Authors:  Agoritsa Varaklioti; Nick Kontodimopoulos; Olga Katsarou; Dimitris Niakas
Journal:  Biomed Res Int       Date:  2014-05-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.